ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
GenMark Diagnostics Inc

GenMark Diagnostics Inc (GNMK)

24.05
0.00
(0.00%)
At close: September 20 4:00PM
24.05
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
24.05
Bid
23.92
Ask
24.39
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
24.05
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GNMK Latest News

GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results

CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...

GenMark ePlexยฎ RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis

CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...

GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (โ€œGenMarkโ€ or the โ€œCompanyโ€), a leading provider of automated, multiplex molecular diagnostic testing...

Study Highlights Potential Clinical Value of ePlexยฎ Blood Culture ID Panels

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the...

GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after...

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (โ€œGenMarkโ€ or the โ€œCompanyโ€), a leading provider of automated, multiplex molecular diagnostic testing...

GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (โ€œGenMarkโ€ or the โ€œCompanyโ€), a leading provider of automated, multiplex molecular diagnostic testing...

GenMark Diagnostics Reports Third Quarter 2020 Results

CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...

GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020

CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
$ 0.3333
(66.65%)
202
TGLTreasure Global Inc
$ 1.03
(51.40%)
1.24M
ULYUrgent ly Inc
$ 1.24
(40.57%)
7.36M
NUKKNukkleus Inc
$ 0.2805
(32.00%)
10.34M
NVVENuvve Holding Corporation
$ 4.60
(17.35%)
7.4k
ZJYLJin Medical International Ltd
$ 2.90
(-28.92%)
206.55k
PRFXPainReform Ltd
$ 0.5796
(-24.83%)
260.6k
MYNZMainz BioMed NV
$ 0.194
(-20.16%)
1.2M
FRESFresh2 Group Ltd
$ 1.45
(-16.18%)
10.2k
CJETChijet Motor Company Inc
$ 2.35
(-16.07%)
109.73k
NVDANVIDIA Corporation
$ 116.08
(0.07%)
13.68M
NUKKNukkleus Inc
$ 0.2805
(32.00%)
10.34M
MAXNMaxeon Solar Technologies Ltd
$ 0.0855
(-6.56%)
9.08M
XPONExpion360 Inc
$ 0.076
(-10.38%)
9.03M
INTCIntel Corporation
$ 22.02
(0.82%)
7.55M

GNMK Discussion

View Posts
mick mick 3 years ago
https://www.otcmarkets.com/stock/GNMK
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
reading congrats GenMark Diagnostics, Inc. (GNMK)'
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 3 years ago


๐Ÿ‘๏ธ0
mick mick 3 years ago


๐Ÿ‘๏ธ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.01 ? 0.02 (0.08%)
Volume: 1,243,229 @04/16/21 5:41:52 PM EDT
Bid Ask Day's Range
23.99 25.0 23.99 - 24.03
GNMK Detailed Quote
๐Ÿ‘๏ธ0
vinsterr vinsterr 4 years ago
My second buyout by Roche! ANDS in 2011 250% gain overnight and this one! Lucky me!

๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
20.68 ? -0.98 (-4.52%)
Volume: 1,223,813 @02/19/21 7:53:11 PM EST
Bid Ask Day's Range
19.3 20.65 20.28 - 21.8
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
https://otcbb.swingtradebot.com/equities/GNMK
๐Ÿ‘๏ธ0
mick mick 4 years ago
https://pennystocks.news/otc/?symbol=GNMK
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
13.99 ? -0.06 (-0.43%)
Volume: 116,280 @12/07/20 11:13:27 AM EST
Bid Ask Day's Range
13.97 14.01 13.83 - 14.296
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
13.79 ? 0.23 (1.70%)
Volume: 408,566 @11/17/20 3:44:44 PM EST
Bid Ask Day's Range
13.79 13.8 13.43 - 13.85
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.68 ? 0.38 (3.36%)
Volume: 853,580 @10/23/20 7:35:16 PM EDT
Bid Ask Day's Range
11.21 12.25 10.97 - 11.585
GNMK Detailed Quote
๐Ÿ‘๏ธ0
eastunder eastunder 4 years ago
GNMK Stock: Why GenMark Diagnostics Is Soaring Today
GenMark just received emergency approval from the FDA for its coronavirus test panel

By Sarah Smith, InvestorPlace Web Content Producer Oct 9, 2020, 9:00 am EDT

https://investorplace.com/2020/10/gnmk-stock-why-genmark-diagnostics-is-soaring-today/

GenMark Diagnostics (NASDAQ:GNMK) is looking to leverage new interest โ€” and new necessity โ€” when it comes to the novel coronavirus. News of its innovative test kit, and emergency-use authorization, is sending GNMK stock higher Friday.

So what exactly is happening? Well, GenMark Diagnostics is a provider of molecular diagnostics. It wants to make testing for all sorts of diseases and bacteria easier, better and more reliant on powerful technology. In fact, the company started back in 1993 with a bold idea for an electronic sensor that could detect DNA.

Clearly, GenMark knows a thing or two about diagnostics. With that in mind, it set out to develop the best test kit for the novel coronavirus. Importantly, it wanted to create something that offered more insight. If a patient has respiratory symptoms but not the coronavirus, GenMark wants to figure out what is causing those symptoms.

That idea is exactly what has GNMK stock popping on Friday. The company took its bold plan, and developed the ePlex Respiratory Pathogen Panel 2 (RP2). Investors should note that not only does this panel test for the coronavirus, but it also provides results for more than 20 different viruses and bacteria. Now, you can know in just two hours whether you have the coronavirus or something less sinister, like the flu or a common cold.

That makes a lot of sense, and thankfully, the U.S. Food and Drug Administration agrees. The regulatory agency just granted the ePlex panel an EUA.

GNMK Stock Pops on New Coronavirus Test
Perhaps one of the best way for investors to understand the importance of the ePlex panel is to examine a real-life example. GenMark tells a story of a nurse, an employee at a hospital that has been testing the panel. When she developed a fever at work, she was immediately able to use the panel. Instead of the coronavirus, she had a common cold.

This matters for two reasons. First, it set a clear path for when she could return to work. Second, it provided more certainty. Simply testing negative for the coronavirus may not give peace of mind. But with the ePlex panel, you know exactly what is causing your symptoms.

As a second โ€” or third โ€” wave of the coronavirus continues to hit the world, and as flu season ramps up, this diagnostic panel will be more important than ever. Consider the wide variety of viruses and bacteria it tests for, and also its two-hour turnaround time. Like with the nurse, the ePlex panel could very well be what investors are waiting for. In other words, it could help bring about a return to normal.

Nothing is a sure thing in the coronavirus drug and vaccine race, but GNMK stock is worthy of staying on your radar.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Sarah Smith is a Web Content Producer for InvestorPlace.com.
๐Ÿ‘๏ธ0
otcmoneydoubler otcmoneydoubler 4 years ago
GNMK COVID NEWS AND THIN ASK ALL THE WAY TO OVER $30. ON WATCH ALL DAY LONG
๐Ÿ‘๏ธ0
whytestocks whytestocks 4 years ago
BREAKING NEWS: $GNMK Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments Canada NewsWire MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST)...

In case you are interested GNMK - Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.6 ? -0.12 (-1.02%)
Volume: 1,638,836 @09/04/20 6:48:00 PM EDT
Bid Ask Day's Range
10.5 11.6 10.6 - 11.793
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
15.23 ? -0.72 (-4.51%)
Volume: 940,835 @08/14/20 5:48:51 PM EDT
Bid Ask Day's Range
15.01 17.4 15.02 - 15.97
GNMK Detailed Quote
๐Ÿ‘๏ธ0
Gpheart2016 Gpheart2016 4 years ago
I must be missing something. Second qtr results: beat on earnings and revenue but stock is down 15%? Maybe a good chance to buy more.
๐Ÿ‘๏ธ0
mick mick 4 years ago
$GNMK GenMark Diagnostics (GNMK)
16.8 ? -1.13 (-6.30%)
Volume: 938,241 @07/24/20 7:00:07 PM EDT
Bid Ask Day's Range
16.75 17.39 16.41 - 17.83
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
$GNMK STRONG HANDS !!!!!
๐Ÿ‘๏ธ0
xray168 xray168 4 years ago
What a run from 4$!
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 4 years ago
* * $GNMK Video Chart 07-08-2020 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
14.09 ? -0.61 (-4.15%)
Volume: 3,638,855 @06/26/20 7:59:56 PM EDT
Bid Ask Day's Range
13.0 14.18 13.92 - 14.99
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago


[-chart]www.stockscores.com/chart.asp?TickerSymbol=GNMK&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
9.14 ? -0.465 (-4.84%)
Volume: 1,415,808 @06/05/20 7:29:15 PM EDT
Bid Ask Day's Range
8.08 10.05 9.06 - 10.05
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
9.63 ? 0.06 (0.63%)
Volume: 2,775,866 @05/27/20 6:44:55 PM EDT
Bid Ask Day's Range
9.12 9.9 8.47 - 9.67
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.835 ? -1.005 (-7.83%)
Volume: 2,397,719 @05/08/20 3:12:05 PM EDT
Bid Ask Day's Range
11.83 11.84 11.52 - 12.3899
GNMK Detailed Quote
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 4 years ago
* * $GNMK Video Chart 05-07-2020 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
mick mick 4 years ago
https://otcbb.swingtradebot.com/equities/GNMK
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
7.61 ? 0.41 (5.69%)
Volume: 2,843,077 @04/16/20 2:34:58 PM EDT
Bid Ask Day's Range
7.6 7.62 7.0 - 7.62
GNMK Detailed Quote
๐Ÿ‘๏ธ0
mick mick 4 years ago


[-chart]www.stockscores.com/chart.asp?TickerSymbol=GNMK&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
๐Ÿ‘๏ธ0
mick mick 4 years ago
8 day-50 day-200 day-https://www.barchart.com/stocks/quotes/GNMK/technical-chart
๐Ÿ‘๏ธ0
mick mick 4 years ago
EARLY RISER PPS $GNMK
๐Ÿ‘๏ธ0
Homebrew Homebrew 4 years ago
So ? That's only meaningless daily short "volume". Merely MMs doing their jobs, to process intra-day orders for thinly traded stocks.

Short INTEREST are open short positions needing to be bought back at some point in the future.
๐Ÿ‘๏ธ0
mick mick 4 years ago
GNMK The short sale volume percent (not short interest) for stock ticker GNMK is 45% on Apr 08, 2020. The short sale volume is 2,560,620. The total volume is 5,664,938. The short sale volume percent is down -6% compare to Apr 07, 2020.
๐Ÿ‘๏ธ0
mick mick 4 years ago
GenMark Diagnostics, Inc (NASDAQ: GNMK) announced preliminary first-quarter results, expecting revenues of about $38.7 million, a 80% year-over-year increase.

The company noted that about 80% gross placements included interest in COVID-19 testing SARS-CoV-2 consumable revenues. Analysts, on average, estimate revenues of $24.8 million.

The company also raised its full-year revenue guidance from $100-$110 million to $112-$122 million, while the consensus calls for revenues of $108.58 million.

The stock climbed 29.56% to $5.83 in after-hours trading.

Zomedica Prices Offering of Common Stock, Warrants
๐Ÿ‘๏ธ0
mick mick 4 years ago
4 analysts offering 12-month price forecasts for Genmark Diagnostics Inc have a median target of 10.00,

with a high estimate of 11.00 and a low estimate of 8.00.

The median estimate represents a +119.30% increase from the last price of 4.56.


https://money.cnn.com/quote/forecast/forecast.html?symb=GNMK
๐Ÿ‘๏ธ0
finna_make_gains finna_make_gains 4 years ago
May options $5 going to be in the money
๐Ÿ‘๏ธ0
mick mick 4 years ago
looks exciting at this level. 'GenMark Diagnostics, Inc. (GNMK)'
๐Ÿ‘๏ธ0
xray168 xray168 4 years ago
buying here at low 4s look safe to me
๐Ÿ‘๏ธ0
mick mick 4 years ago
Investors in GenMark Diagnostics, Inc. GNMK need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2020 $7.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for GenMark shares, but what is the fundamental picture for the company? Currently, GenMark is a Zacks Rank #3 (Hold) in the Medical - Instruments industry that ranks in the Top 17% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has narrowed our Zacks Consensus Estimate for the current quarter from a loss of 17 cents per share to a loss of 16 cents in that period.

Given the way analysts feel about GenMark right now, this huge implied volatility could mean thereโ€™s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?
๐Ÿ‘๏ธ0
Pedro2004 Pedro2004 4 years ago
LOL...the company is going to dilute this POS back under $4 dollars.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock